What we do Samrat Pharmachem Ltd manufactures pharmaceutical chemicals and iodine derivatives for local and international pharmaceutical and chemical industries, focusing on efficiency with two production plants. |
Founded in 1,992 |
Market share Recognized exporter with growing international acceptance; among leading iodine derivative producers in India. |
Problem solved Provides essential pharmaceutical chemical intermediates meeting quality and capacity demands of pharma and chemical sectors. |
Top clients or who we serve Serves pharmaceutical and chemical manufacturers globally; primarily B2B customer base. |
Key management - |
Our journey and innovations Started in 1992; expanded capacity in 1996; GMP certified in 2015; capacity enhancement in 2019; flourishing export growth. |
Where we operate Primarily India with exports to global pharmaceutical and chemical markets. |
Top products or what we offer Specializes in iodine derivatives and pharmaceutical intermediates, supporting drug and chemical production. |
Top brands - |
Raw materials needed Iodine and chemical raw materials for pharmaceutical intermediates production. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenues mainly recurring through stable pharmaceutical supply contracts and export orders. |
Our industry position Well-positioned in niche iodine derivatives segment with Export House certification and expanding global footprint. |
Financial highlights FY2025 revenue Rs. 285.86 Cr; net profit Rs. 7.11 Cr; EBITDA improved significantly to Rs. 11.21 Cr from Rs. 3.85 Cr previous year. |
Geographical revenue split - |
Order book - |
Whats driving growth Growing pharmaceutical demand, export expansion, capacity enhancements, and GMP certification drive growth. |
Our future plans Plans to expand production capacity further and boost exports to consolidate global market presence. |
Our green promise Implements safety, health, environment policies; maintains pollution control and energy conservation measures. |
Our people and values Employs 28 staff with a strong safety and health culture fostering employee well-being and compliance. |
Key challenges ahead Market competition, raw material price volatility, regulatory compliance, and export market fluctuations. |
Interesting facts GMP compliance and Export House status achieved; operates two plants for optimized production. |
Risks and strategy Mitigates risks via diversification, strong compliance, and maintaining financial stability with low debt. |
